Abstract
There have been controversies on the prophylactic effect of hydroxychloroquine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). We describe a patient, 60-year old Korean woman, with coronavirus disease 2019 (COVID-19) who had been taking hydroxychloroquine for 6 months. Her serum and saliva concentrations of hydroxychloroquine were 280 μg/L and 4,890 μg/L, respectively. The present case raises concerns on hydroxychloroquine's role as a prophylactic agent for COVID-19.
Original language | English |
---|---|
Article number | e231 |
Journal | Journal of Korean Medical Science |
Volume | 35 |
Issue number | 24 |
DOIs | |
State | Published - 22 Jun 2020 |
Bibliographical note
Publisher Copyright:© 2020 The Korean Academy of Medical Sciences.
Keywords
- COVID-19
- Hydroxychloroquine
- Prophylaxis
- SARS-CoV-2